Two Drugs Equal in Preventing Early Breast Cancer’s Return: Study
Women with ductal carcinoma in situ had similar outcomes with tamoxifen, anastrozoleContinue Reading
Women with ductal carcinoma in situ had similar outcomes with tamoxifen, anastrozoleContinue Reading
Half of all injection drug users live in rural, suburban areasContinue Reading
Nitrates reduce activity, quality of life, researchers find
Continue Reading
Designed for women diagnosed with breast cancer
Continue Reading
Researchers also found lower risk of complications that can interrupt breast cancer treatmentContinue Reading
Afinitor lowered risk by a third, while Xgeva lowered chances by 18 percent, researchers reportContinue Reading
Here’s what to do if you need a course
Continue Reading
Study finds both treatments can helpContinue Reading
Clotting factor sanctioned for von Willebrand disease
Continue Reading
Clotting factor sanctioned for von Willebrand disease
Continue Reading
Together, warfarin and sulfonylureas raise risk of hospitalization, study showsContinue Reading
International research finds prasugrel isn’t effective at easing sufferingContinue Reading
International research finds prasugrel isn’t effective at easing sufferingContinue Reading
Wolman disease triggers fat buildup, leading to heart and liver problemsContinue Reading
© 2021 TheHealthCast.com - All Rights Reserved.